274 online
 
Most Popular Choices
Share on Facebook 61 Printer Friendly Page More Sharing Summarizing
Positive News    H3'ed 10/10/23

Breaking access barriers and bringing quality healthcare closer to the people in Meghalaya

By       (Page 2 of 2 pages) Become a premium member to see this article and all articles as one long page.   No comments

Citizen News Service - CNS
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)
As per the India TB Report 2023, there are 55 Truenat molecular test machines deployed for TB testing in Meghalaya by 2022, which performed 29,086 tests in the same year. Of those who got tested for TB on Truenat, 1829 people were detected with TB disease, and 124 people had rifampicin-resistant TB. In 2022, 244 people were tested for extrapulmonary TB in Meghalaya on one of these Truenat molecular test machines, out of which 12 people were found to have active disease.

Bobby Ramakant - CNS (Citizen News Service)
(Bobby Ramakant is a World Health Organization (WHO) Director-General's WNTD Awardee 2008 and Health Science Editor at CNS (Citizen News Service). Follow him on Twitter @BobbyRamakant or read: www.bit.ly/BobbyRamakant)

- Shared under Creative Commons

Next Page  1  |  2

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The chasm between TB and HIV continues

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Why are shorter, safer and more effective treatments for drug-resistant TB not being rolled out?

Journey of a TB survivor from pain to strength

To View Comments or Join the Conversation:

Tell A Friend